SHR-2173

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameSHR-2173
Drug Alias NameSHR-2173SHR2173
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesLupus Erythematosus, SystemicPurpura, Thrombocytopenic, Idiopathic +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangdong Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangdong Hengrui Pharmaceutical Co LtdAtridia Pty Ltd
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesLupus Erythematosus, SystemicPurpura, Thrombocytopenic, Idiopathic +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A